Capital Flow Monitor · Sponsors · CIK 1661059
NextCure, Inc.
9000 VIRGINIA MANOR ROAD, BELTSVILLE, MD, 20705 · 240-399-4900
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$21.5M
Sold
$21.5M
% sold
100.0%
Investors
12
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-10 | D ·current | 506(b) | $21.5M | $21.5M | 100.0% | 12 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Michael Richman — Executive Officer / Director, Beltsville, MD
- Steven P. Cobourn — Executive Officer, Beltsville, MD
- David Kabakoff — Director, Beltsville, MD
- Elaine V. Jones — Director, Beltsville, MD
- John G. Houston — Director, Beltsville, MD
- Stephen Webster — Director, Beltsville, MD
- Ellen G. Feigal — Director, Beltsville, MD
- Anne Borgman — Director, Beltsville, MD
- Udayan Guha — Executive Officer, Beltsville, MD
- Timothy Mayer — Executive Officer, Beltsville, MD
- Sourav Kundu — Executive Officer, Beltsville, MD
- Kevin Shaw — Executive Officer, Beltsville, MD
Placement agents
- H.c. Wainwright & Co., Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.